Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility

Kidney International

Volumn 52, Issue 5, 1997, Pages 1302-1312

  Mott, Joni D ^a   Khalifah, Raja G ^a   Nagase, Hideaki ^a   Shield III, Charles F ^a   Hudson, Julie K ^a   Hudson, Billy G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN;

ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS BASEMENT MEMBRANE; LENS CAPSULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION;

EID: 0030658055     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.455     Document Type: Article

References (83)

1. NATHAN DM: Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1685, 1993
2. CLARK CM, LEE DA: Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 332:1210-1217, 1995
3. TIMPL R: Structure and activity of basement membrane proteins. Eur J Biochem 180:487-502, 1989
4. YURCHENCO PD: Assembly of laminin and type IV collagen in basement membrane networks, in Extracellular Matrix Assembly and Structure, edited by YURCHENCO PD, BIRK DE, MECHAM RP. San Diego, Academic Press, 1994, pp 351-388
5. TIMPL R, ROHRBACH DH (editors): Molecular and Cellular Aspects of Basement Membranes. San Diego, Academic Press, 1993
6. THE DIABETES CONTROL, COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
7. BROWNLEE M, VLASSARA H, CERAMI A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537, 1984
8. RUDERMAN NB, WILLIAMSON JR, BROWNLEE M: Glucose and diabetic vascular disease. FASEB J 6:2905-2914, 1992
9. BROWNLEE M: Advanced protein glycosylation in diabetes and aging. Ann Rev Med 46:223-234, 1995
10. VLASSARA H, BUCALA R, STRIKER L: Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151, 1994
11. DANIELS BS, HAUSER EB: Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model. Diabetes 41:1415-1421, 1992
12. ZIYADEH FN: Renal tubular basement membrane and collagen type IV in diabetes mellitus. Kidney Int 43:114-120, 1993
13. COHEN MP, CLEMENTS RS, COHEN JA, SHEARMAN CW: Glycated albumin promotes a generalized vasculopathy in db/db mouse. Biochem Biophys Res Commun 218:72-75, 1996
14. COHEN MP, ZIYADEH FN: Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. J Am Soc Nephrol 7:183-190, 1996
15. ZIYADEH FN, MOGYOROSI A, KALLURI R: Early and advanced nonenzymatic glycation products in the pathogenesis of diabetic kidney disease. Exp Nephrol 5:2-9, 1997
16. RECKELHOFF JF, TYGART VL, MITIAS MM, WALCOTT JL: STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats. Diabetes 42:1425-1432
17. COHEN MP, HUD E, Wu VY, ZIYADEH FN: Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription. Mol Cell Biochem 151:61-67, 1995
18. KITAMURA M, KITAMURA A, MITARAI T, MARUYAMA N, NAGASAWA R, YOSHIDA H, TAKAHASHI T, SAKAI O: Gene expression of metalloproteinase and its inhibitor in mesangial cells exposed to high glucose. Biochem Biophys Res Commun 185:1048-1054, 1992
19. NAKAMURA T, FUKUI M, EBIHARA I, OSADA S, TOMINO Y, KOIDE H: Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. Ren Phvsiol Biochem 17:316-325, 1994
20. SHANKLAND SJ, LY H, THAI K, SCHOLEY JW: Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats. J Am Soc Nephrol 7:97-104, 1996
21. ANDERSON SS, WU K, NAGASE H, STETTLER-STEVENSON WG, KIM Y, TSILIBARY EC: Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells. Cell Adhesion Commun 4:89-101, 1996
22. HUDSON BG, REEDERS ST, TRYGGVASON K: Type IV collagen: Structure, gene organization, and role in human diseases. J Biol Chem 268:26033-26036, 1993
23. KAHSAI TZ, ENDERS GC, GUNWAR S, BRUNMARK C, WIESLANDER J, KALLURI R, ZHOU J, NOELKEN ME, HUDSON BG: Seminiferous tubule basement membranes: Composition and organization of type IV collagen chains, and the linkage of 3(IV) and 5(IV) chains. J Biol Chem (in press)
24. TIMPL R, WIEDEMANN H, VAN DELDEN V, FURTHMAYR G, KUHN K: A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 120:203-221, 1981
25. REISER KM: Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med 196:17-29, 1991
26. REISER K, MCCORMICK RJ, RUCKER RB: Enzymatic and nonenzymatic cross-linking of collagen and elastin. FASEB J 6:2439-2449, 1992
27. PAUL RG, BAILEY AJ: Glycation of collagen: The basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol 28:1297-1310, 1996
28. GARLICK RL, BUNN FH, SPIRO RG: Nonenzymatic glycation of basement membranes from human glomeruli and bovine sources: Effects of diabetes and age. Diabetes 37:1144-1150, 1988
29. TSILIBARY EC, CHARONIS AS, REGER LA, WOHLHUETER RM, FURCHT LT: The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain of type IV collagen. J Biol Chem 263:4302-4308, 1988
30. HAITOGLOU CS, TSILIBARY EC, BROWNLEE M, CHARONIS AS: Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J Biol Chem 267:12404-12407, 1992
31. CHARONIS AS, TSILIBARY EC: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes 41(Suppl 2):49-51, 1992
32. ANDERSON SS, TSILIBARY EC, CHARONIS AS: Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane. J Clin Invest 92:3045-3052, 1993
33. BAILEY AJ, SIMS TJ, AVERY NC, MILES CA: Chemistry of collagen cross-links: Glucose-mediated covalent cross-linking of type IV collagen in lens capsules. Biochem J 296:489-496, 1993
34. HARDING JJ: Nonenzymatic covalent posttranslational modification of proteins in viva. Adv Prot Chem 37:247-334, 1985
35. BAYNES JW, MONNIER VM (editors): The Maillard Reaction in Aging, Diabetes, and Nutrition. New York, Alan R. Liss, 1989
36. FINOT PA, AESCHBACHER HU, HURRELL RF, LIARDON R: The Maillard Reaction in Food Processing, Human Nutrition and Physiology, Basel, Birkhauser, 1990
37. WELLS-KNECHT KJ, BRINKMANN E, WELLS-KNECHT MC, LITCHFIELD JE, AHMED MU, REDDY S, ZYZAK DV, THORPE SR, BAYNES JW: New biomarkers of Maillard reaction damage to proteins. Nephrol Dial Transplant 11(Suppl 5):41-47, 1996
38. BAYNES JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
39. BAYNES JW: Reactive oxygen in the aetiology and complications of diabetes, in Drugs, Diet and Disease (vol 2), edited by IOANNIDES C, FLATT PR, London, Ellis Horwood, 1995, pp 201-240
40. SELL DR, MONNIER VM: Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264:21597-21602, 1989
41. GRANDHEE SK, MONNIER VM: Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose and ascorbate as pentosidine precursors. J Biol Chem 266:11649-11653, 1991
42. DYER GD, BLACKLEDGE JA, THORPE SR, BAYNES JW: Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 266:11654-11660, 1991
43. AHMED MU, THORPE SR, BAYNES JW: Identification of N-carboxymethyllysine as a degradation product of fructosyllysine in glycated protein. J Biol Chem 261:4889-4894, 1986
44. REDDY S, BICHLER J, WELLS-KNECHT KJ, THORPE SR, BAYNES JW: N-(Carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34:10872-10878, 1995
45. IKEDA K, HIGASHI T, HIROYUKI S, JINNOUCHI Y, YOSHIDA M, ARAKI T, UEDA S, HORIUCHI S: N-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35:8075-8083, 1996
46. YANG CW, VLASSARA H, PETEN EP, HE CJ, STRIKER GE, STRIKER LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440, 1994
47. LUBEC G, POLLAK A: Reduce susceptibility of nonenzymatically glucosylated glomerular basement membrane to proteases. Renal Physiol 3:4-8, 1980
48. WOESSNER JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154, 1991
49. NAGASE H: Matrix metalloproteinases. A mini-review. Contrib Nephrol 107:85-93, 1994
50. NAGASE H: Matrix metalloproteinases, in Zinc Metalloproteases in Health and Disease, edited by HOOPER NM, London, Taylor & Francis (in press)
51. KEFALIDES NA, HOWARD P, OHNO N: Heterogeneity in basement membranes determines their structure and function, in Basement Membranes, edited by SHIBATA S, New York, Elseviers, 1985, pp 73-87
52. PECZON BD, MCCARTHY CA, MERRITT RB: Probing the subunit structure of cow anterior lens capsule with the detergent, sodium dodecyl sulfate. Exp Eye Res 35:643-651, 1982
53. FREYTAG JW, OHNO M, HUDSON BG: Bovine renal glomerular basement membrane. Assessment of proteolysis during isolation. Biochem Biophys Res Commun 72:796-802, 1976
54. SPIRO RG: Studies on renal glomerular basement membrane. Preparation and chemical composition. J Biol Chem 242:1915-1922, 1967
55. FOX JW, BUTKOWSKI RJ, HUDSON BG: Detergent-prepared glomerular basement membrane is composed of a heterogeneous group of polypeptides. J Biol Chem 256:9313-9315, 1981
56. REDDY GK, GUNWAR S, KALLURI R, HUDSON BG, NOELKEN ME: Structure and composition of type IV collagen of bovine aorta. Biochim Biophys Acta 1157:241-251, 1993
57. NAGASE H, ENGHILD JJ, SUZUKI K, SALVESEN G: Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry 29:5783-5789, 1990
58. MORODOMI T, OGATA Y, SASAGURI Y, MORIMATSU M, NAGASE H: Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J 285:603-611, 1992
59. TIMONEDA J, GUNWAR S, MONFORT G, SAUS J, NOELKEN ME, HUDSON BG: Unusual dissociative behavior of the noncollagenous domain (hexamer) of basement membrane collagen during electrophoresis and chromatofocusing. Connect Tissue Res 24:169-186, 1990
60. SELL DR, MONNIER VM: Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagenrich tissue. Connect Tissue Res 19:77-92, 1989
61. BUTKOWSKI RJ, WIESLANDER J, WISDOM BJ, BARR JF, NOELKEN ME, HUDSON BG: Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen. J Biol Chem 260: 3739-3747, 1985
62. KHALIFAH RG, TODD P, BOOTH AA, YANG SX, MOTT JD, HUDSON BG: Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies. Biochemistry 35:4645-4654, 1996
63. ENGVALL E: Enzyme immunoassay ELISA and EMIT. Meth Enzymol 70:419-439, 1980
64. BOOTH AA, KHALIFAH RG, TODD P, HUDSON BG: In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways. J Biol Chem 272:5430-5437, 1997
65. MONNIER VM, KOHN RR, CERAMI A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81:583-587, 1984
66. ODETTI P, TRAVERSO N, COSSO L, NOBERASCO G, PRONZATO MA, MARINARI UM: Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats. Diabetologia 39:1440-1447, 1996
67. PONGOR S, ULRICH PC, BENCSATH FA, CERAMI A: Aging of proteins: Isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc Natl Acad Sci USA 81:2684-2688, 1984
68. NJOROGE FG, FERNANDES AA, MONNIER VM: Mechanism of formation of the putative advanced glycosylation end product and protein cross-link 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole. J Biol Chem 263:10646-10652, 1988
69. NAGARAJ RH, MONNIER VM: Isolation and characterization of a blue fluorophore from human eye lens crystallins: In vitro formation from Maillard reaction with ascorbate and ribose. Biochem Biophys Acta 1116:34-42, 1992
70. IENAGA K, NAKAMURA K, HOCHI T, NAKAZAWA Y, FUKUNAGA Y, KAKITA H, NAKANO K: Crosslines, fluorophores in the AGE-related cross-linked proteins. Contrib Nephrol 112:42-51, 1995
71. GRAHAM L: A comprehensive survey of the acid-stable fluorescent cross-links formed by ribose with basic amino acids, and partial characterization of a novel Maillard cross-link. Biochim Biophys Acta 1297:9-16, 1996
72. NAKAMURA K, NAKAZAWA Y, IENAGA K: Acid-stable fluorescent advanced glycation end products: Vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 232: 227-230, 1997
73. BEJARANO PA, NOELKEN ME, SUZUKI K, HUDSON BG, NAGASE H: Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). Biochem J 256:413-419, 1988
74. MURPHY G, WARD R, HEMBRY RM, REYNOLDS JJ, KUHN K, TRYGGVASON K: Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J 258:463-472, 1989
75. WILHELM SM, COLLIER IE, MARMER BL, EISEN AZ, GRANT GA, GOLDBERG GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221, 1989
76. NAGASE H, FIELDS GB: Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. Biopolymers 40:399-416, 1996
77. MATRISIAN LM: The matrix-degrading metalloproteinases. Bioessays 14:455-463, 1992
78. FESSLER LI, DUNCAN KG, FESSLER JH, SALO T, TRYGGVASON K: Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem 259:9783-9789, 1984
79. RAABE HM, MOLSEN H, MLINARIC SM, ACIL Y, SINNECKER GH, NOTBOHM H, KRUSE K, MULLER PK: Biochemical alterations in collagen IV induced by in vitro glycation. Biochem J 319:699-704, 1996
80. SCHLEICHER ED, WAGNER E, NERLICH AG: Increased accumulation of the glycoxidation product N-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99:457-468, 1997
81. MUTHUKUMARAN G, BLUMBERG B, KURKINEN M: The complete primary structure for the alpha 1-chain of mouse collagen IV. Differential evolution of collagen IV domains. J Biol Chem 264:6310-6317, 1989
82. HOSTIKKA SL, TRYGGVASON K: The complete primary structure of the alpha 2 chain of human type IV collagen and comparison with the alpha 1(IV) chain. J Biol Chem 263:19488-19493, 1988
83. PIHLAJANIEMI T, POHJOLAINEN ER, MYERS JC: Complete primary structure of the triple-helical region and the carboxyl-terminal domain of a new type IV collagen chain, alpha 5(IV). J Biol Chem 265:13758-13766, 1990